Point72 Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Point72 Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-175,000	Closed	-$20.2M	–	3025
2023 Q3	$20.2M	Buy	+175,000	New	+$18.8M	0.06%	401
2022 Q4	–	Sell	-2,094,400	Closed	-$130M	–	1915
2022 Q3	$130M	Buy	+2,094,400	New	+$146M	0.52%	32
2021 Q4	–	Sell	-203,378	Closed	-$22.3M	–	1421
2021 Q3	$22.3M	Sell	203,378 -852,493	-81%	-$88.5M	0.1%	276
2021 Q2	$98.9M	Buy	+1,055,871	New	+$97.2M	0.44%	42
2020 Q4	–	Sell	-443,270	Closed	-$34.4M	–	1241
2020 Q3	$34.4M	Buy	+443,270	New	+$30.5M	0.18%	155
2019 Q3	–	Sell	-5,200	Closed	-$125K	–	1628
2019 Q2	$125K	Buy	+5,200	New	+$132K	﹤0.01%	1018
2019 Q1	–	Sell	-312,800	Closed	-$6.11M	–	1340
2018 Q4	$6.11M	Buy	+312,800	New	+$6.13M	0.03%	513
2018 Q2	–	Sell	-1,312,900	Closed	-$18.6M	–	1282
2018 Q1	$18.6M	Buy	1,312,900 +940,100	+252%	+$13.9M	0.08%	305
2017 Q4	$5.44M	Sell	372,800 -2,436,700	-87%	-$34.2M	0.02%	575
2017 Q3	$35.6M	Sell	2,809,500 -844,000	-23%	-$10.7M	0.16%	165
2017 Q2	$43.4M	Buy	3,653,500 +3,226,300	+755%	+$40.1M	0.24%	112
2017 Q1	$6.31M	Sell	427,200 -145,700	-25%	-$2.36M	0.04%	486
2016 Q4	$9.27M	Buy	572,900 +63,500	+12%	+$1.15M	0.06%	332
2016 Q3	$9.23M	Buy	509,400 +149,600	+42%	+$2.92M	0.06%	292
2016 Q2	$5.93M	Sell	359,800 -659,600	-65%	-$10.7M	0.04%	391
2016 Q1	$16.9M	Buy	+1,019,400	New	+$17.8M	0.13%	193
2015 Q4	–	Sell	-900	Closed	-$18K	–	916
2015 Q3	$18K	Sell	900 -324,100	-100%	-$10.2M	﹤0.01%	731
2015 Q2	$11.3M	Buy	325,000 +91,100	+39%	+$2.78M	0.08%	300
2015 Q1	$6.07M	Sell	233,900 -2,380,800	-91%	-$43.6M	0.04%	407
2014 Q4	$33.7M	Buy	2,614,700 +1,680,304	+180%	+$21M	0.24%	145
2014 Q3	$11.5M	Buy	+934,396	New	+$10.9M	0.09%	266

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asset Management's HZNP Position: Q4 2023 in Review

Point72 Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 175,000 shares — an estimated $20.2M sold.

Point72 Asset Management first reported a position in HZNP in Q3 2014 and held it in 21 quarters. The position peaked at $130M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Point72 Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Point72 Asset Management sold 175,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $20.2M.
Point72 Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 21 quarters.
Point72 Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $130M in Q3 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.